Endocrine Abstracts

Introduction: Surgery remains the first-line treatment of clinically non-functioning pituitary adenomas (NFPA). However, the presence of somatostatin receptors (SSTR) in these tumours forms the basis of clinical use of somatostatin analogues (SSA). Visualisation of SSTR in scintigraphy is compulsory to introduce SSA therapy in NFPA.Aim: To assess the effectiveness of long-term somatostatin analogues treatment on tumour volume and visual field in patients...